Johnson & JohnsonvsMedpace

JNJ and MEDP stock compared: price, dividend, valuation and results, from SEC filings.

MEDP

Medpace Holdings, Inc.

$633.98

Value $18.0B

-1.99%
MEDP's page

Johnson & Johnson (JNJ) has a market value of $644B and Medpace (MEDP) $18.0B. Over the last year, with dividends, JNJ moved +36.6% and MEDP +7.4%. The P/E is 40.0 for JNJ and 34.8 for MEDP. Dividend yield: JNJ 1.98%, MEDP none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    JNJ$644B

    MEDP$18.0B

    JNJ is 36 times MEDP

  • Revenue, 12 months

    JNJ$99.3B

    MEDP$2.8B

    JNJ is 35 times MEDP

  • Net income, 12 months

    JNJ$16.1B

    MEDP$518M

    JNJ is 31 times MEDP

  • Operating margin

    JNJ–

    MEDP21.4%

  • ROIC

    JNJ12.4%

    MEDP105.8%

    93.4 points apart

  • P/E

    JNJ40.0

    MEDP34.8

    JNJ is 1.2 times MEDP

  • Dividend yield

    JNJ2.0%

    MEDP0.0%

    2.0 points apart

  • 5-year return

    JNJ+89.1%

    MEDP+180.2%

    91.1 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

JNJ+89.1%

MEDP+180.2%

10020030020222023202420252026
Returns by period
PeriodJNJWith dividendsMEDPWith dividends
1 year since November 18, 2025+36.6%Price +33.6%+7.4%Price +7.4%
3 years since November 17, 2023+94.2%+24.8% a yearPrice +78.3%+131.4%+32.3% a yearPrice +131.4%
5 years since November 18, 2021+89.1%+13.6% a yearPrice +64.5%+180.2%+22.9% a yearPrice +180.2%
10 years since November 21, 2016+202.7%+11.7% a yearPrice +132.3%+1,664.0%+33.2% a yearPrice +1,664.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

JNJJohnson & JohnsonMEDPMedpace

Valuation

JNJMEDP
Valuation
Price$267.14$633.98
Market value$644B$18.0B
Enterprise value (EV)$671B$17.3B
P/E40.034.8
P/E, 5-year median21.934.5
P/B7.930.8
EV/EBIT37.828.5
Free cash flow yield3.2%3.7%

Results and growth

JNJMEDP
Results and growth
Revenue, 12 months$99.3B$2.8B
Net income, 12 months$16.1B$518M
Free cash flow, 12 months$20.6B$668M
Earnings per share, 12 months$6.59$18.01
Revenue growth, year on year6.1%20.0%
Revenue growth a year, past+2.7%over 5 years+22.3%over 5 years
EPS growth a year, past+14.9%over 5 years+31.8%over 5 years

Margins and returns on capital

JNJMEDP
Margins and returns on capital
Gross margin67.6%–
Operating margin–21.4%
Net margin16.2%18.2%
ROIC12.4%105.8%
ROE19.7%109.3%

Balance sheet

JNJMEDP
Balance sheet
Cash$17.2B$705M
Total debt$44.7B$171M
Net debt / EBITDA1.1-1.1
Interest cover18.0×–

Dividends and buybacks

JNJMEDP
Dividends and buybacks
Dividend yield2.0%–
Dividend per share, 12 months$5.28–
Dividend growth a year, past+5.3%over 5 years–
Buyback yield0.9%5.1%
Shareholder yield2.9%5.1%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: JNJ or MEDP

Didn't find what you were looking for?

Ask us
Which is bigger, Johnson & Johnson or Medpace?

By market value, Johnson & Johnson ($644B) is about 35.8 times Medpace ($18.0B), at today's prices.

How did JNJ and MEDP stock do over the last 10 years?

Since November 21, 2016, JNJ's price moved +132.3% and MEDP's +1,664.0%. With dividends: JNJ +202.7% (+11.7% a year), MEDP +1,664.0% (+33.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, JNJ or MEDP?

The dividend yield at today's price is 1.98% for Johnson & Johnson and none for Medpace. Over the last twelve months they paid $5.28 and – per share.

What is the P/E of JNJ and MEDP?

At today's price, the P/E is 40.0 for JNJ and 34.8 for MEDP. The median of the last five years was 21.9 and 34.5, which shows where each stands against its own past.

Which has the higher profit margins, Johnson & Johnson or Medpace?

Over the last twelve months, the net margin was 16.2% for Johnson & Johnson and 18.2% for Medpace, and the operating margin – and 21.4%. Revenue was $99.3B and $2.8B.

Which is the better investment, Johnson & Johnson or Medpace?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.